BioAtla, Inc.

NasdaqCM:BCAB Stock Report

Market Cap: US$42.7m

BioAtla Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BCAB?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2,810,3814.76%
VC/PE Firms4,835,1118.19%
Individual Insiders6,018,65010.2%
Institutions8,513,01314.4%
General Public36,858,36162.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 36.29% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.19%
Acorn Bioventures
4,835,111US$3.5m0%1.18%
5.4%
Jay Short
3,185,094US$2.3m0.62%no data
4.76%
Opoka Investment Fund Co
2,810,331US$2.0m-20.8%no data
3.3%
The Vanguard Group, Inc.
1,945,795US$1.4m9.12%no data
2.33%
Tang Capital Management, LLC
1,374,076US$994.8k0%0.03%
1.58%
Acadian Asset Management LLC
930,462US$673.7k-37.7%no data
1.55%
Scott Smith
914,095US$661.8k207%no data
1.36%
Renaissance Technologies LLC
800,631US$579.7k6.15%no data
1.34%
Carolyn Short
793,547US$574.5k0%no data
0.89%
Deutsche Asset & Wealth Management
525,353US$380.4k0%no data
0.84%
Geode Capital Management, LLC
495,211US$358.5k0.6%no data
0.81%
BlackRock, Inc.
480,933US$348.2k0%no data
0.58%
Millennium Management LLC
341,322US$247.1k0%no data
0.46%
Citadel Advisors LLC
274,036US$198.4k0%no data
0.43%
Susquehanna International Group, LLP
252,583US$182.9k238%no data
0.33%
Jane Street Group, LLC
194,377US$140.7k1,030%no data
0.32%
Richard Waldron
186,525US$135.0k8.27%no data
0.28%
Christian Vasquez
167,623US$121.4k8.27%no data
0.26%
State Street Global Advisors, Inc.
151,377US$109.6k0%no data
0.23%
Lawrence Steinman
137,266US$99.4k150%no data
0.23%
Mary Gray
136,204US$98.6k153%no data
0.22%
Edward Williams
131,700US$95.4k259%no data
0.22%
Sylvia McBrinn
130,240US$94.3k266%no data
0.2%
Eric Sievers
118,220US$85.6k4.32%no data
0.19%
Susan Moran
111,114US$80.4k286%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/26 15:19
End of Day Share Price 2025/12/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioAtla, Inc. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas ShraderBTIG
Justin ZelinBTIG
Suranjit MukherjeeBTIG